No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
313 |
4. Check minimum number of eventsNone |
313 |
5. Include endpointsNone |
313 |
6. Filter based on genotype QC (FinnGen only) |
270 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Squamous cell neoplasms and carcinoma of cervix
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of cervix uteri
- Malignant neoplasm of cervix uteri, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 270 | 270 | - |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | - |
| Median age at first event (years) | 43.12 | 43.12 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 289
- Matched controls
- 2890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
286.3
225
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
176.8
151
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
146.7
128
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
22.7
136.1
117
84
H02AB02
ATC
dexamethasone; systemic
73.0
114.5
63
11
ULA02
NOMESCO Finland
Kolposcopy
13.0
111.1
162
258
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
12.5
95.9
123
162
128
Kela drug reimbursment
Cancers of female genital organs
+∞
92.8
84
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
10.5
91.3
153
280
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.7
82.0
137
246
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
38.9
72.9
46
14
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
22.4
70.8
55
30
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
15.2
62.7
60
49
LEB00
NOMESCO Finland
Biopsy of vagina
23.0
59.3
45
23
JN4BD
NOMESCO Finland
Extensive body CT
16.0
58.7
54
41
XX3DW
NOMESCO Finland
Time consuming IT work
13.2
54.8
57
53
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
53.9
50
*
WF002
NOMESCO Finland
Radical radiotherapy
205.4
50.7
51
*
A04AA01
ATC
ondansetron; systemic, rectal
13.2
49.8
51
46
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
12.7
49.4
52
49
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.3
49.0
39
22
Z51.5
ICD-10 Finland
Palliative care
18.5
43.4
36
22
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
41.7
39
*
8070/3-C53.1
ICD-O-3
Squamous cell carcinoma, NOS, of exocervix
+∞
40.6
38
*
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.2
40.3
60
89
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
39.5
37
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
38.4
36
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
37.3
35
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
36.2
34
*
B01AB10
ATC
tinzaparin; parenteral
6.4
35.3
68
132
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
47.4
34.1
41
10
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
34.0
32
*
ZXC96
NOMESCO Finland
Robot assisted procedure
84.3
33.7
37
5
A03FA01
ATC
metoclopramide; systemic, rectal
4.7
33.3
107
323
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
127.9
32.4
34
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
31.9
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
31.9
30
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
30.8
29
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
30.8
29
*
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
28.6
27
*
JN4AD
NOMESCO Finland
Body CT examination
8.3
26.5
37
50
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
26.5
25
*
A04AA02
ATC
granisetron; systemic, transdermal
284.7
26.1
26
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.2
25.9
89
277
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.4
24
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
24.3
23
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
24.3
23
*
A04AD12
ATC
aprepitant; systemic
+∞
23.2
22
*
8070/3-C53.0
ICD-O-3
Squamous cell carcinoma, NOS, of endocervix
+∞
23.2
22
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
248.9
23.0
23
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
22.2
21
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
22.0
130
570
ZX120
NOMESCO Finland
Intravenous
6.4
21.8
39
69
ZX090
NOMESCO Finland
Other technic of radiotherapy
118.6
20.9
22
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
118.6
20.9
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.7
20.4
27
34
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
20.0
19
*
C53.10
ICD-10 Finland
Malignant tumor of the exocervix without histology
+∞
20.0
19
*
L03AA13
ATC
pegfilgrastim; parenteral
214.1
19.8
20
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
19.0
18
*
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
+∞
19.0
18
*
WZC30
NOMESCO Finland
Teaching
4.1
18.1
58
168
B01AB05
ATC
enoxaparin; parenteral
3.1
18.1
112
494
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
17.9
17
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
17.9
17
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
17.9
17
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
39.5
17.9
22
6
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
101.4
17.8
19
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.9
17.6
158
850
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.8
16
*
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
16.8
16
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
16.8
16
*
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
16.8
16
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
16.8
16
*
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
+∞
16.8
16
*
C53.91
ICD-10 Finland
Squamous cell carcinoma in an unspecified location in the cervix
+∞
16.8
16
*
WW500
NOMESCO Finland
Blood transfusion
13.3
16.8
29
24
N02AA05
ATC
oxycodone; systemic
3.6
16.3
64
213
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.7
15.9
23
32
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
15.8
15
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
19.1
15.4
23
13
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
84.5
14.7
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
L03AA02
ATC
filgrastim; parenteral
+∞
14.7
14
*
UKC02
NOMESCO Finland
Cystoscopy
3.8
14.6
49
146
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
10.9
14.3
27
27
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
14.6
14.0
23
17
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
5.6
13.7
27
52
1801A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Exocervix
+∞
13.6
13
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
13.6
13
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
13.6
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
146.6
13.6
14
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
146.6
13.6
14
*
N87.1
ICD-10 Finland
Moderate cervical dysplasia
6.3
13.3
23
39
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
39.4
12.3
15
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
5.7
11.5
22
41
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
11.5
11
*
130
Kela drug reimbursment
Malignant tumour
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
4.8
10.7
25
56
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
+∞
10.5
10
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
33.9
10.4
13
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.3
9.5
22
32
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
9.5
32
95
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
103.3
9.5
10
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.4
9.4
24
58
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
38.0
9.1
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
28.5
8.5
11
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
8.4
8
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.8
7.9
15
16
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.4
7.6
14
14
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
82.1
7.5
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C53.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of cervix uteri
+∞
7.3
7
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
4.6
7.1
17
39
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.6
7.1
17
27
WX402
NOMESCO Finland
General anaesthesia
2.3
7.0
63
317
WX892
NOMESCO Finland
Monitored bed care
3.3
6.8
26
84
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
6.7
14
18
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
6.7
38
154
JAH01
NOMESCO Finland
Laparoscopy
3.7
6.6
21
60
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
71.4
6.5
7
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
71.4
6.5
7
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
6.3
19
52
JN5KS
NOMESCO Finland
Very extensive PET-MRI of body metabolism
+∞
6.3
6
*
JN5DS
NOMESCO Finland
PET-MRI of body metabolism
+∞
6.3
6
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
+∞
6.3
6
*
18011, ,
ICD-8 Finland
+∞
6.3
6
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
4.1
6.3
17
43
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
5.6
6.3
17
32
L02BG04
ATC
letrozole; oral
4.3
6.2
16
39
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
67
159
5.18
27.58
2.5
1.6
—
—
—
0
0
148
681
3.40
23.42
2.6
1.5
—
—
—
0
0
181
1056
2.91
17.14
3.9
2.4
—
—
estimate
—
0
0
18
10
19.08
12.21
1.1
1.4
—
—
—
0
0
19
16
12.62
11.01
2.3
1.8
—
—
—
0
0
128
745
2.29
10.54
4.8
3.0
—
—
—
0
0
144
892
2.22
10.07
6.8
3.5
34.25
36.63
g/l
3.92
135
827
98
518
2.35
10.03
3.5
1.8
—
—
—
0
0
39
140
3.06
8.57
2.1
1.5
—
—
—
0
0
212
1703
1.92
5.62
10.2
5.4
86.19
73.65
u/l
1.69
206
1591
165
1258
1.73
4.88
16.5
6.5
4.05
4.07
e9/l
0.02
154
1079
16
47
3.55
4.82
1.9
1.4
4.35
1.28
ug/l
0.69
16
42
143
1055
1.70
4.72
9.5
4.9
1.21
1.22
mmol/l
1.23
119
918
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
35
4.46
4.70
3.2
2.9
0.41
0.38
iu/ml
—
9
27
57
334
1.88
4.08
4.5
2.7
5.49
3.99
e6/l
0.30
35
138
162
1267
1.63
4.05
5.2
3.6
6.40
6.39
mmol/l
0.03
154
1156
88
592
1.70
3.95
4.3
2.9
0.62
0.43
e6/l
0.40
71
416
31
147
2.24
3.91
4.5
2.5
4.51
4.57
kpa
0.04
31
141
194
1596
1.66
3.89
7.0
4.6
5056.14
3256.47
e6/l
—
7
19
107
764
1.64
3.80
5.0
2.0
2.35
2.35
mmol/l
0.07
100
690
37
191
2.07
3.79
3.5
2.9
—
—
—
0
0
33
164
2.14
3.72
3.9
2.4
0.19
0.22
e6/l
0.11
33
153
9
16
5.77
3.68
2.7
2.0
11.86
70.82
u/ml
—
9
16
45
256
1.90
3.52
5.5
5.2
—
—
—
0
0
19
76
2.61
3.45
2.0
1.8
—
—
—
0
0
22
96
2.40
3.36
1.7
1.8
—
—
—
0
0
58
370
1.71
3.11
4.4
2.6
1.57
1.08
e6/l
0.38
35
176
17
71
2.48
2.86
1.7
1.8
—
—
—
0
0
74
1014
0.64
2.82
2.0
1.8
1.56
1.34
mmol/l
1.52
58
892
16
66
2.51
2.76
1.9
1.1
—
—
—
0
0
160
1319
1.48
2.71
5.3
3.6
0.14
0.01
estimate
0.43
29
248
32
179
1.89
2.64
7.2
5.4
5.16
5.18
kpa
0.03
32
172
32
179
1.89
2.64
7.2
5.4
11.12
11.79
kpa
0.38
32
172
12
42
2.94
2.58
2.8
4.2
36.14
22.42
mg/l
—
7
30
214
2355
0.65
2.55
4.2
4.7
4.90
4.82
mmol/l
0.77
206
2229
38
228
1.77
2.52
13.3
4.2
1.03
1.04
mmol/l
0.06
38
201
93
696
1.50
2.52
4.9
3.7
0.00
0.00
estimate
0.50
27
239
9
27
3.41
2.41
1.1
1.1
—
—
—
0
0
28
155
1.89
2.40
2.0
2.1
597.47
5077.36
u/l
1.75
14
64
46
301
1.63
2.24
2.0
1.8
—
—
—
0
0
5
9
5.63
2.22
1.8
1.0
—
—
—
0
0
5
9
5.63
2.22
1.8
1.0
—
—
—
0
0
215
2343
0.68
2.10
4.1
4.6
1.52
1.57
mmol/l
0.99
207
2204
41
266
1.63
2.07
2.6
1.7
28.42
29.22
s
0.47
41
260
243
2243
1.52
1.86
21.9
10.6
81.81
84.68
ml/min/173m2
1.18
226
2029
5
12
4.22
1.83
1.6
1.4
2051.80
1040.08
mg
—
5
12
13
61
2.18
1.74
1.9
2.6
8.09
10.46
mg/l
0.67
13
56
5
13
3.89
1.72
4.6
4.3
488.40
669.00
u/ml
—
5
13
151
1299
1.34
1.68
5.4
3.6
0.00
0.00
estimate
-0.00
29
251
10
40
2.55
1.68
1.5
2.3
—
—
—
0
0
223
2390
0.71
1.63
4.5
5.2
2.87
2.82
mmol/l
0.39
212
2252
5
15
3.37
1.53
1.4
1.3
—
—
—
0
0
17
95
1.84
1.46
2.1
2.4
0.58
0.60
%
0.07
17
95
17
95
1.84
1.46
2.1
2.4
1.70
1.18
%
0.79
17
95
9
179
0.49
1.45
1.6
1.4
—
47.19
—
0
12
151
1319
1.30
1.43
5.4
3.6
46.20
5.82
estimate
0.41
30
259
206
2220
0.75
1.38
3.7
3.9
1.35
1.20
mmol/l
2.36
198
2071
117
992
1.30
1.37
5.7
3.4
0.00
0.03
estimate
1.05
22
208
252
2380
1.46
1.34
23.7
11.6
26.24
19.03
mg/l
2.77
219
1850
17
100
1.74
1.26
2.1
1.6
—
—
—
0
0
15
85
1.81
1.25
1.3
1.1
—
—
—
0
0
15
85
1.81
1.25
1.3
1.1
—
—
—
0
0
7
145
0.47
1.23
1.4
1.5
—
—
—
0
0
10
52
1.96
1.07
1.6
1.4
32.47
29.58
u/l
—
10
44
85
713
1.27
1.05
5.0
3.0
0.00
0.02
estimate
0.68
24
205
73
602
1.28
1.03
4.7
3.5
1.01
1.02
kg/l
0.88
54
389
5
23
2.19
0.98
1.6
1.4
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
23
158
1.50
0.97
1.2
1.4
—
—
—
0
0
12
70
1.75
0.94
1.4
1.2
—
—
—
0
0
221
2326
0.79
0.92
4.8
4.5
5.86
5.73
mmol/l
0.85
210
2163
30
220
1.41
0.92
1.8
1.8
—
—
—
0
0
6
29
2.09
0.90
1.0
1.4
—
—
—
0
0
6
30
2.02
0.87
1.7
2.2
102.00
105.83
mmol/l
—
6
30
6
30
2.02
0.87
1.7
2.2
1.22
1.18
mmol/l
—
6
30
29
214
1.39
0.86
1.4
1.3
37.53
24.18
iu/l
1.13
24
185
12
72
1.70
0.86
1.1
1.2
296.40
341.80
ug/g
—
5
45
44
351
1.30
0.81
1.6
1.7
968.25
1153.97
nmol/l
0.75
36
266
21
148
1.45
0.80
4.0
1.6
66.54
67.51
g/l
0.40
21
140
93
813
1.21
0.78
3.3
3.3
24.63
105.56
ng/l
0.49
51
489
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
6
34
1.78
0.76
1.5
1.1
—
—
—
0
0
6
34
1.78
0.76
1.5
1.1
—
—
—
0
0
6
34
1.78
0.76
1.5
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
19
133
1.46
0.75
1.9
2.0
12.09
5.01
iu/ml
—
8
35
20
275
0.71
0.75
1.5
1.5
1.40
1.30
%
0.43
15
244
6
109
0.54
0.74
1.5
1.6
—
—
—
0
0
21
153
1.40
0.69
1.8
1.4
—
—
—
0
0
19
259
0.71
0.68
1.7
1.8
3.70
3.44
mmol/l
0.48
14
197
66
565
1.22
0.68
1.8
1.7
1.29
0.94
mg/l
0.46
54
421
27
210
1.32
0.61
1.9
1.8
—
—
—
0
0
64
553
1.20
0.61
2.7
3.0
5029.33
1226.22
ng/l
1.03
56
466
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
161
1714
0.86
0.58
3.4
3.7
—
—
—
0
0
6
35
1.73
0.58
1.7
1.1
—
—
—
0
0
6
35
1.73
0.58
1.7
1.1
—
—
—
0
0
6
35
1.73
0.58
1.7
1.1
—
—
—
0
0
13
91
1.45
0.54
2.5
2.3
45.46
38.81
u/l
0.53
13
84
6
39
1.55
0.53
1.0
1.4
—
184.00
—
0
5
6
39
1.55
0.53
1.0
1.4
—
—
—
0
0
17
126
1.37
0.53
1.8
1.3
186.55
261.91
miu/ml
0.55
11
62
12
168
0.70
0.52
1.5
1.5
—
—
—
0
0
6
40
1.51
0.52
2.7
1.8
—
—
—
0
0
60
526
1.18
0.49
2.6
2.1
318.66
306.23
umol/l
0.40
50
471
7
48
1.47
0.47
1.0
1.1
—
—
—
0
0
7
50
1.41
0.45
1.1
1.7
—
—
—
0
0
52
456
1.17
0.43
1.6
1.6
409.13
39000457.30
pmol/l
0.80
46
400
20
159
1.28
0.41
8.4
5.0
1.51
1.22
mmol/l
0.83
20
154
0
15
0.00
0.41
0.0
4.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
3.08
—
0
12
0
18
0.00
0.40
0.0
1.0
—
1.11
—
0
9
56
625
0.87
0.38
1.4
1.7
—
—
—
0
0
21
171
1.25
0.37
2.0
2.0
62.36
74.96
ml/min/173m2
0.63
11
72
13
168
0.76
0.37
1.0
1.1
—
—
—
0
0
6
41
1.47
0.36
1.7
2.0
—
—
—
0
0
5
80
0.62
0.36
1.2
1.5
50.71
52.75
ug/l
—
5
80
14
178
0.78
0.35
1.5
1.5
—
—
—
0
0
10
73
1.38
0.35
1.6
1.3
—
—
—
0
0
228
2336
0.89
0.32
5.9
6.0
1.77
1.80
mu/l
0.17
217
2211
97
1035
0.91
0.31
2.1
2.1
88.08
98.39
pmol/l
1.38
68
526
7
96
0.72
0.31
1.0
1.2
1.51
1.61
g/l
—
7
96
7
98
0.71
0.31
1.0
1.2
1.01
0.89
g/l
—
7
98
68
626
1.11
0.29
2.9
2.2
3.34
2.77
mg/l
1.07
58
548
63
684
0.90
0.28
1.5
1.3
0.51
2.29
u/ml
1.51
21
204
50
549
0.89
0.27
1.3
1.3
7.48
8.68
u/ml
0.09
25
223
213
2075
1.10
0.27
29.0
15.2
331.74
331.06
g/l
0.50
208
2058
185
1797
1.08
0.23
4.5
4.3
14.23
10.52
mm/h
2.35
175
1694
14
116
1.22
0.22
9.9
3.7
5.03
5.29
kpa
0.68
14
111
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
4.1
—
600.42
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
8.15
—
0
13
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
141
1361
1.07
0.20
3.8
3.3
165.41
69.48
ug/l
2.36
132
1288
42
385
1.11
0.20
1.9
1.9
—
—
—
0
0
54
578
0.92
0.19
1.4
1.4
13.78
34.58
iu/ml
3.25
18
170
13
109
1.20
0.19
9.2
5.4
24.78
24.58
mmol/l
0.07
13
109
14
119
1.19
0.18
1.3
1.9
—
—
—
0
0
11
91
1.22
0.18
2.5
1.7
—
—
—
0
0
31
289
1.08
0.11
1.6
1.8
—
—
—
0
0
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
45
429
1.06
0.09
1.9
2.0
—
—
—
0
0
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
6
56
1.07
0.08
1.5
1.4
0.49
0.51
nmol/l
—
6
51
43
413
1.05
0.07
3.7
3.6
171.34
293.72
ng/l
0.27
29
266
67
689
0.96
0.07
2.3
2.0
157.11
138.94
u/l
0.19
62
657
71
691
1.04
0.07
4.6
3.8
34.04
6.82
mg/mmol
1.14
49
407
32
335
0.95
0.06
1.6
2.0
3.15
3.28
ratio
0.28
25
275
116
1141
1.03
0.06
3.1
2.5
73.24
77.73
nmol/l
1.00
109
1044
10
90
1.12
0.05
1.6
1.3
—
—
—
0
0
205
2066
0.97
0.05
5.0
5.0
14.62
14.47
pmol/l
0.40
194
1937
66
645
1.03
0.05
1.7
1.7
16.19
21.05
nmol/l
2.92
57
561
10
93
1.08
0.02
1.6
1.7
—
—
—
0
0
23
231
1.00
0.00
1.5
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.26
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
50.67
—
0
6
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
104.25
—
0
8
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
163
1630
1.00
-0.00
3.6
3.0
47.98
36.35
u/l
0.80
157
1553
0
6
0.00
-0.00
0.0
1.3
—
247.57
—
0
6
0
6
0.00
-0.00
0.0
2.7
—
0.83
—
0
6
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_SQUAM – Squamous cell neoplasms and carcinoma of cervix
GWS hits: 1
This endpoint is excluded from FinRegistry analyses (omitted endpoint).